Table of Contents page: European Urology Open Science

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Full length article

The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)

Claude C. Schulman,
Ragnar Asplund,
François Desgrandchamps,
Udo Jonas

Published online: December 14, 2004

p1-8

Cardiovascular Safety of Tamsulosin Modified Release in the Fasted and Fed State in Elderly Healthy Subjects

Martin C. Michel,
Cees Korstanje,
Walter Krauwinkel

Published online: December 22, 2004

p9-14

The Pharmacokinetic Profile of Tamsulosin Oral Controlled Absorption System (OCAS^®)

Martin C. Michel,
Cees Korstanje,
Walter Krauwinkel,
Mirjam Kuipers

Published online: December 22, 2004

p15-24

Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): Efficacy and Tolerability in a Phase 2b Dose-Response Study

Christopher R. Chapple,
Jerzy Lorenz,
Raymond Mortensen,
...
Mario O. Reis,
Claude C. Schulman,
Ingrid van der Putten-Slob

Published online: December 14, 2004

p25-32

Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): Efficacy and Tolerability in a Placebo and Active Comparator Controlled Phase 3a Study

Christopher R. Chapple,
Salman H. Al-Shukri,
Bernard Gattegno,
...
Oncko B. van Vierssen Trip,
Viktor Vik,
Ingrid van der Putten-Slob

Published online: December 14, 2004

p33-44

Comparison of Vascular α1-Adrenoceptor Antagonism of Tamsulosin in Oral Controlled Absorption System (OCAS) and Modified Release (MR) Formulations

Comparison of Vascular α₁-Adrenoceptor Antagonism of Tamsulosin in Oral Controlled Absorption System (OCAS) and Modified Release (MR) Formulations

Martin C. Michel,
Cees Korstanje,
Walter Krauwinkel,
Michael Shear,
Jonathan Davies,
Adrian Quartel

Published online: December 31, 2004

p45-52

Cardiovascular Safety of the Oral Controlled Absorption System (OCAS) Formulation of Tamsulosin Compared to the Modified Release (MR) Formulation

Martin C. Michel,
Cees Korstanje,
Walter Krauwinkel,
Michael Shear,
Jonathan Davies,
Adrian Quartel

Published online: December 31, 2004

p53-60

The Impact of Tamsulosin Oral Controlled Absorption System (OCAS) on Nocturia and the Quality of Sleep: Preliminary Results of a Pilot Study

Bob Djavan,
Shirin Milani,
Jonathan Davies,
John Bolodeoku

Published online: January 06, 2005

p61-68

Latest

Popular Articles

Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer

C10 Beneficial effects of cranberries on prostate health: Evidence from a randomized controlled trial

PSA Levels and the Probability of Prostate Cancer on Biopsy

Latest Articles

Prior Robotic Console Expertise May Improve Basic Skills at the New Hugo RAS Simulator: Results from a Cohort Trial and Implications for Skill Transference Across Platforms

A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy

Urodrill - a novel MRI-guided endoscopic biopsy technique to sample and molecularly classify muscle-invasive bladder cancer without fractionating the specimen during transurethral resection

For Authors

Society

Journal Information

Companion Journals

Contact

Follow Us

February 2005

Editorial Board

Editorial Board

Full length article

The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)

Cardiovascular Safety of Tamsulosin Modified Release in the Fasted and Fed State in Elderly Healthy Subjects

The Pharmacokinetic Profile of Tamsulosin Oral Controlled Absorption System (OCAS^®)

Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): Efficacy and Tolerability in a Phase 2b Dose-Response Study

Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): Efficacy and Tolerability in a Placebo and Active Comparator Controlled Phase 3a Study

Comparison of Vascular α₁-Adrenoceptor Antagonism of Tamsulosin in Oral Controlled Absorption System (OCAS) and Modified Release (MR) Formulations

Cardiovascular Safety of the Oral Controlled Absorption System (OCAS) Formulation of Tamsulosin Compared to the Modified Release (MR) Formulation

The Impact of Tamsulosin Oral Controlled Absorption System (OCAS) on Nocturia and the Quality of Sleep: Preliminary Results of a Pilot Study

Index

Subject Index